PERISCOPE CAPITAL INC. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PERISCOPE CAPITAL INC. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q1 2023$1,594,524
-71.7%
149,300
-72.8%
0.07%
-69.5%
Q4 2022$5,636,423
-25.7%
549,359
-27.0%
0.24%
+10.5%
Q3 2022$7,590,000
+26.3%
752,259
+25.4%
0.22%
+37.5%
Q2 2022$6,009,000
+0.2%
599,700
+0.1%
0.16%
+3.9%
Q1 2022$5,997,000599,4000.15%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders